QQ客服 官方微博 反馈留言

	ARNTL hypermethylation promotes tumorigenesis and inhibits cisplatin sensitivity by activating CDK5 transcription in nasopharyngeal carcinoma.
	Peng, Hao; Zhang, Jian; Zhang, Pan-Pan; Chen, Lei; Tang, Ling-Long; Yang, Xiao-Jing; He, Qing-Mei; Wen, Xin; Sun, Ying; Liu, Na
刊名	Journal of Experimental & Clinical Cancer Research
	2019
卷号	Vol.38 No.1
ISSN号	1756-9966
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4743293
专题	湖南大学
作者单位	1.Department of Radiation Oncology, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, 510060, Guangdong, People's Republic of China 2.Department of Experimental Research, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, 510060, Guangdong, People's Republic of China
推荐引用方式 GB/T 7714	Peng, Hao,Zhang, Jian,Zhang, Pan-Pan,et al. ARNTL hypermethylation promotes tumorigenesis and inhibits cisplatin sensitivity by activating CDK5 transcription in nasopharyngeal carcinoma.[J]. Journal of Experimental & Clinical Cancer Research,2019,Vol.38 No.1.
APA	Peng, Hao.,Zhang, Jian.,Zhang, Pan-Pan.,Chen, Lei.,Tang, Ling-Long.,...&Ma, Jun.(2019).ARNTL hypermethylation promotes tumorigenesis and inhibits cisplatin sensitivity by activating CDK5 transcription in nasopharyngeal carcinoma..Journal of Experimental & Clinical Cancer Research,Vol.38 No.1.
MLA	Peng, Hao,et al."ARNTL hypermethylation promotes tumorigenesis and inhibits cisplatin sensitivity by activating CDK5 transcription in nasopharyngeal carcinoma.".Journal of Experimental & Clinical Cancer Research Vol.38 No.1(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。